Clinical trial · Interventional
Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer
Virtual Environment Radiotherapy (VERT) to Improve Patients' Compliance to Radiotherapy (RT) in Prostate Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Purpose of the study 1. To assess whether offering visual information to patients with prostate cancer prior to receiving RT increases the participant's compliance. 2. To assess whether increased compliance translates into reduced side effects from RT (assessed with a quality of life questionnaire). Type of study. This is a randomised control trial which will include 170 patients with the histological diagnosis of prostate cancer in the study arm and 170 patients with the histological diagnosis of prostate cancer in the control/standard arm.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Carcinoma | Prostate Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| VERT system | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Study Arm
- description
- Patients with a histological diagnosis of prostate cancer are shown how Radiotherapy is planned and given using 3D images on the VERT (Virtual Environment Radiotherapy) system prior to the start of Radiotherapy.
- interventionNames
- Other: VERT system
- type
- OTHER
- label
- Control Arm
- description
- Patients with a histological diagnosis of prostate cancer who are shown how Radiotherapy is planned and given using 3D images on the VERT (Virtual Environment Radiotherapy) system following completion of Radiotherapy.
- interventionNames
- Other: VERT system
Primary outcomes (1)
- measure
- Volume of bladder measurement in cm3
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with the histological diagnosis of prostate cancer due to receive radical RT. * Patients with prostate cancer deemed fit enough to complete a course of radical RT to their prostate area. * Patients able to give informed consent. Exclusion Criteria: * The only exclusion criteria is for participants unable to understand the study aims and therefore unable to give informed consent.
References
Publications (0)
Data not yet available